Education
About Us
Working with TipRanks
Follow Us
Jeffrey Hessekiel Insider Profile
4 Followers
Jeffrey Hessekiel, EVP & GC at Exelixis, holds 87.30K shares in Cytokinetics (Ticker: CYTK), holds 694.39K shares in Exelixis (Ticker: EXEL).
Profitable Transactions
5 out of 10 Profitable Transactions
Average Return
+1.70%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Jeffrey Hessekiel holds in companies
Most Profitable Insider Trade
The most profitable trade made by Jeffrey Hessekiel
Jeffrey Hessekiel's Trading History
Exelixis
May 16, 2025
EVP & GC
Uninformative Sell
2.67M
$28.66M
Cytokinetics
Nov 17, 2025
Chief Legal & Admin Officer
Uninformative Buy
―
$5.39M
List of latest transactions for each holding click on a transaction to see Jeffrey Hessekiel's performance on stock
You May Also Like
Jeffrey Hessekiel insider profile FAQ
What is the percentage of profitable transactions made by Jeffrey Hessekiel?
The percentage of profitable transactions made by Jeffrey Hessekiel is 50%.
What is the average return per transaction made by Jeffrey Hessekiel?
The average return per transaction made by Jeffrey Hessekiel is 1.70%.
What stocks does Jeffrey Hessekiel hold?
Jeffrey Hessekiel holds: EXEL, CYTK stocks.
What was Jeffrey Hessekiel’s latest transaction?
Jeffrey Hessekiel latest transaction was an Uninformative Buy of ―.
What was Jeffrey Hessekiel's most profitable transaction?
Jeffrey Hessekiel’s most profitable transaction was an Informative Sell of EXEL stock on September 28, 2017. The return on the trade was 26.80%.
What is Jeffrey Hessekiel's role in Exelixis?
Jeffrey Hessekiel's role in Exelixis is EVP & GC.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.